Clinical trial
Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma
NCT00456716 · Swedish Medical Center, Other · Completed
Key facts
| NCT number | NCT00456716 |
|---|---|
| Title | Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma |
| Official title | A Phase II Trial of Sorafenib in BAC or Never-Smokers With Any Lung Adenocarcinoma |
| Lead sponsor | Swedish Medical Center, Other |
| Collaborators | Bayer Industry Amgen |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | sorafenib |
| Enrollment | 5 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Apr 5, 2007 |
| Last update posted | Mar 4, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: